Radiolabeling of new generation magnetic poly(HEMA–MAPA) nanoparticles with 131I and preliminary investigation of its radiopharmaceutical potential using albino Wistar rats
- 19 August 2013
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 56 (14) , 708-716
Abstract
In this study, N‐methacryloyl‐l‐phenylalanine (MAPA) containing poly(2‐hydroxyethylmethacrylate) (HEMA)‐based magnetic poly(HEMA–MAPA) nanobeads [mag‐poly(HEMA–MAPA)] were radiolabeled with 131I [131I‐mag‐poly(HEMA–MAPA)], and the radiopharmaceutical potential of 131I‐mag‐poly(HEMA–MAPA) was investigated. Quality control studies were carried out by radiochromatographic method to be sure that 131I binded to mag‐poly(HEMA–MAPA) efficiently. In this sense, binding yield of 131I‐mag‐poly(HEMA–MAPA) was found to be about 95–100%. In addition to this, optimum radiodination conditions for 131I‐mag‐poly(HEMA–MAPA) were determined by thin‐layer radiochromatography studies. In addition to thin‐layer radiochromatography studies, lipophilicity (partition coefficient) and stability studies for 131I‐mag‐poly(HEMA–MAPA) were realized. It was determined that lipophilicities of mag‐poly(HEMA–MAPA) and 131I‐mag‐poly(HEMA–MAPA) were 0.12 ± 0.01 and 1.79 ± 0.76 according to ACD/logP algorithm program, respectively. Stability of the radiolabeled compound was investigated in time intervals given as 0, 30, 60, 180, and 1440 min. It was found that 131I‐mag‐poly(HEMA–MAPA) existed as a stable complex in rat serum within 60 min. After that, biodistribution and scintigraphy studies were carried out by using albino Wistar rats. It was determined that the most important 131I activity uptake was observed in the breast, the ovary, and the pancreas. Scintigraphy studies well supported biodistribution results. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Guided delivery of polymer therapeutics using plasmonic photothermal therapyNano Today, 2012
- Polymer–drug conjugates as nano-sized medicinesCurrent Opinion in Biotechnology, 2011
- Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacyJournal of Controlled Release, 2011
- A Simple and Safe Method for 131 I Radiolabeling of Rituximab for Myeloablative High-Dose RadioimmunotherapyCancer Biotherapy and Radiopharmaceuticals, 2009
- Phenylalanine containing hydrophobic nanospheres for antibody purificationBiotechnology Progress, 2008
- Metabolic comparison of radiolabeled aniline- and phenol-phthaleins with 131INuclear Medicine and Biology, 2008
- Investigation of loading and release in PVA‐based hydrogelsJournal of Applied Polymer Science, 2002
- Diffusive contribution to permeation of hydrogel contact lenses: theoretical model and experimental evaluation by nuclear magnetic resonance techniquesPolymer, 2002
- Hydrogels for biomedical applicationsAdvanced Drug Delivery Reviews, 2002
- Water transport in crosslinked 2‐hydroxyethyl methacrylatePolymer Engineering & Science, 2000